Results 271 to 280 of about 141,551 (313)
Some of the next articles are maybe not open access.
Oligometastasis in Head and Neck Squamous Cell Carcinoma
International Journal of Radiation Oncology*Biology*Physics, 2022Up to 40% of patients who present with, or later develop, metastatic disease from head and neck squamous cell carcinoma have oligometastatic disease, defined as 5 or fewer sites of metastasis. Patients with limited number of metastases clearly have improved overall survival compared with those with more disseminated metastases, but the risk of, and ...
Dominic H, Moon, David J, Sher
openaire +2 more sources
Hypercalcemia in Head and Neck Squamous-Cell Carcinoma
American Journal of Clinical Oncology, 1990Hypercalcemia was previously considered a terminal phenomenon in advanced head and neck squamous-cell carcinoma. We report on six patients with head and neck carcinoma and hypercalcemia refractory to conventional measures. Three patients had stage IV tumor not amenable to surgery or radiation therapy and three others had carcinoma recurrent after ...
K S, Sridhar, A M, Hussein
openaire +2 more sources
Chemoprevention of squamous cell carcinoma of the head and neck
Current Opinion in Oncology, 2007The aim of this article is to summarize progress in understanding of the biology of squamous cell carcinoma of the head and neck and of trials to prevent malignant conversion of oral premalignant lesions and the development of second primary tumors in those already treated for squamous cell carcinoma of the head and neck.The understanding of squamous ...
John M, Wrangle, Fadlo R, Khuri
openaire +2 more sources
Squamous cell carcinoma of the head and neck in children
International Journal of Pediatric Otorhinolaryngology, 2019To discuss the presentation, evaluation, and management of squamous cell carcinoma of the head and neck in the pediatric population.Medical records of pediatric (≤20 years) patients treated for squamous cell carcinoma of the head and neck between 1996 and 2016 were reviewed.
Natasha D. Dombrowski +6 more
openaire +2 more sources
Afatinib in squamous cell carcinoma of the head and neck
Expert Opinion on Pharmacotherapy, 2016Recently new data on the efficacy of afatinib in head and neck squamous cell carcinoma (HNSCC) have been published.We searched the literature for published and ongoing studies with afatinib in HNSCC. Phase I data and results of phase II and III studies of afatinib in HNSCC are discussed.
Specenier, Pol, Vermorken, Jan
openaire +3 more sources
Head and neck squamous cell carcinoma in childhood
Medical and Pediatric Oncology, 1998Squamous cell carcinoma (SCC) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. The patients reported in the literature are isolated cases and their management is always difficult because there is no large experience or a convincing theory to support treatment decisions for every ...
M B, de Carvalho +10 more
openaire +2 more sources
Cetuximab In Squamous Cell Carcinoma of the Head and Neck
Future Oncology, 2006Surgery and radiotherapy are the standard treatment options for patients with squamous cell carcinoma of the head and neck (SCCHN). Chemotherapy and chemoradiotherapy are new alternatives for locally advanced disease, particularly induction chemotherapy for patients with unresectable tumors.
Ricardo, Hitt +2 more
openaire +2 more sources
Basaloid squamous cell carcinoma of the head and neck
Current Opinion in Otolaryngology & Head and Neck Surgery, 2004Basaloid squamous cell carcinoma is an uncommon variant of squamous cell carcinoma and was first described as a distinct entity in 1986. Basaloid squamous cell carcinoma seems to have a poorer survival rate than classical squamous cell carcinoma. On the basis of a critical literature survey, we attempt to evaluate if basaloid squamous cell carcinoma is
Zbären P, Nuyens M, Stauffer E
openaire +3 more sources
Angiogenesis in head and neck squamous cell carcinoma
Clinical Otolaryngology and Allied Sciences, 2000Tumour angiogenesis has recently attracted a great deal of attention as a critical part of oncogenesis and a necessary prerequisite for a malignant phenotype. Research into this process not only offers new insights into tumour biology but is also leading to the development of realistic novel and minimally toxic anti-tumour therapies.
J J, Homer, J, Greenman, N D, Stafford
openaire +2 more sources
The economics of squamous cell carcinoma of the head and neck
Current Opinion in Otolaryngology & Head & Neck Surgery, 2007The current review presents a brief overview of the recent literature on the costs of squamous cell carcinoma of the head and neck (SCCHN), one of the most common forms of cancer. SCCHN is a relatively deadly disease. Approximately 50% of patients survive to 5 years, and surgery and chemoradiotherapy can leave survivors with pain, disfigurement, and ...
Joseph, Menzin +2 more
openaire +2 more sources